Study design
This randomized, double-blinded, controlled trial was conducted at the Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China, from 6/1/2022 to 2/28/2023, which performed in accordance with the declaration of Helsinki. The Consolidated Standards of Reporting Trials (CONSORT) recommendations were followed in this study [